Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?
Roy M Bremnes1, Tom Donnem1, Lill-Tove Busund1
11 Institute of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway ; 2 Department of Oncology, University Hospital of Northern Norway, Tromsø, Norway ; 3 Institute of Medical Biology, The Arctic University of Norway, Tromsø, Norway ; 4 Department of Pathology, University Hospital of Northern Norway, Tromsø, Norway.
Annals of Translational Medicine
|May 11, 2016
Abstract
No abstract available in PubMed .
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:39lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K